{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:28:19Z","timestamp":1768685299711,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00277-024-05804-x","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T07:01:56Z","timestamp":1716447716000},"page":"2545-2549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy"],"prefix":"10.1007","volume":"103","author":[{"given":"Francesca Romana","family":"Iovene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Santinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Armiento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Sarlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Bancone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Erculei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Sanhust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariadomenica","family":"Divona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Zenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Cantonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Rigacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"5804_CR1","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3389\/fimmu.2019.01506","volume":"10","author":"G Genovese","year":"2019","unstructured":"Genovese G et al (2019) New insights into the pathogenesis of Bullous Pemphigoid: 2019 update. Front Immunol 10:1506","journal-title":"Front Immunol"},{"key":"5804_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jaad.2017.05.006","volume":"77","author":"L Atzmony","year":"2017","unstructured":"Atzmony L et al (2017) Association of bullous pemphigoid with malignancy: a systematic review and meta-analysis. J Am Acad Dermatol 77:691\u2013699","journal-title":"J Am Acad Dermatol"},{"key":"5804_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/jid.2014.547","volume":"135","author":"F Schulze","year":"2015","unstructured":"Schulze F et al (2015) Malignancies in pemphigus and pemphigoid diseases. J Invest Dermatol 135:1445\u20131447","journal-title":"J Invest Dermatol"},{"key":"5804_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00403-013-1399-5","volume":"306","author":"E Ong","year":"2014","unstructured":"Ong E, Goldacre R, Hoang U, Sinclair R, Goldacre M (2014) Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999\u20132011. Arch Dermatol Res 306:75\u201380","journal-title":"Arch Dermatol Res"},{"key":"5804_CR5","doi-asserted-by":"publisher","first-page":"1155181","DOI":"10.3389\/fimmu.2023.1155181","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y et al (2023) Associations between bullous pemphigoid and hematological diseases: literature review on mechanistic connections and possible treatments. Front Immunol 14:1155181","journal-title":"Front Immunol"},{"key":"5804_CR6","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and Histiocytic\/Dendritic neoplasms. Leukemia 36:1703\u20131719","journal-title":"Leukemia"},{"key":"5804_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA et al (2022) International Consensus classification of myeloid neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140:1200\u20131228","journal-title":"Blood"},{"key":"5804_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140:1345\u20131377","journal-title":"Blood"},{"key":"5804_CR9","doi-asserted-by":"publisher","first-page":"e2020050","DOI":"10.5826\/dpc.1003a50","volume":"10","author":"V Di Lernia","year":"2020","unstructured":"Di Lernia V, Casanova DM, Goldust M, Ricci C (2020) Pemphigus Vulgaris and Bullous Pemphigoid: update on diagnosis and treatment. Dermatol Pract Concept 10:e2020050","journal-title":"Dermatol Pract Concept"},{"key":"5804_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1046\/j.1365-2141.1997.4763281.x","volume":"99","author":"JE Parker","year":"1997","unstructured":"Parker JE et al (1997) Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol 99:939\u2013944","journal-title":"Br J Haematol"},{"key":"5804_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/7445","volume":"5","author":"DA Frank","year":"1999","unstructured":"Frank DA, Mahajan S, Ritz J (1999) Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 5:444\u2013447","journal-title":"Nat Med"},{"key":"5804_CR12","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1182\/blood-2013-05-503847","volume":"122","author":"RF Schlenk","year":"2013","unstructured":"Schlenk RF et al (2013) The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA. Blood 122:1576\u20131582","journal-title":"Blood"},{"key":"5804_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/1346-8138.13079","volume":"43","author":"R Balestri","year":"2016","unstructured":"Balestri R et al (2016) Malignancies in bullous pemphigoid: a controversial association. J Dermatol 43:125\u2013133","journal-title":"J Dermatol"},{"key":"5804_CR14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fimmu.2019.01259","volume":"10","author":"JH Kim","year":"2019","unstructured":"Kim JH, Kim S-C (2019) Paraneoplastic Pemphigus: paraneoplastic autoimmune disease of the skin and Mucosa. Front Immunol 10:1259","journal-title":"Front Immunol"},{"key":"5804_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1046\/j.1365-2133.1997.d01-1210.x","volume":"136","author":"P Modiano","year":"1997","unstructured":"Modiano P et al (1997) Bullous pemphigoid in association with cutaneous lesions specific to a myelodysplastic syndrome. Br J Dermatol 136:402\u2013405","journal-title":"Br J Dermatol"},{"key":"5804_CR16","doi-asserted-by":"publisher","first-page":"S390","DOI":"10.5021\/ad.2011.23.S3.S390","volume":"23","author":"YY Lee","year":"2011","unstructured":"Lee YY, Bee PC, Lee CK, Naiker M, Ismail R (2011) Bullous pemphigoid in an elderly patient with myelodysplastic syndrome and refractory anemia coupled with excess of blast. Ann Dermatol 23:S390\u2013S392","journal-title":"Ann Dermatol"},{"key":"5804_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/10428199909167405","volume":"32","author":"F Bauduer","year":"1999","unstructured":"Bauduer F, Barteau A, Truchet S, Massot-Bordenave J, Ducout L (1999) Bullous pemphigoid associated with the transformation of a preexisting myelodysplastic syndrome. Leuk Lymphoma 32:399\u2013400","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05804-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05804-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:07:26Z","timestamp":1720109246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05804-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5804"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05804-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}